Bluefin Capital Management, LLC Amarin Corp Plcuk Transaction History

Bluefin Capital Management, LLC

  • $1.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$1.09 - $1.67 $2,180 - $3,340
2,000 Added 2.01%
101,388 $111,000
Q2 2022

Aug 15, 2022
SELL
$1.13 - $3.69 $188,257 - $614,754
-166,600 Reduced 62.63%
99,388 $181,000
Q1 2022

May 16, 2022
BUY
$2.85 - $3.73 $758,065 - $992,135
265,988 New
265,988 $875,000

Others Institutions Holding AMRN

# of Institutions
177
Shares Held
65.1M
Call Options Held
258K
Put Options Held
98K
View Full List

About AMARIN CORP PLCUK

AMRN Quotes by TradingView
  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $202M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Bluefin Capital Management, LLC Portfolio

Follow Bluefin Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bluefin Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bluefin Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email